Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Robert W. Baird 

Ocular Therapeutix Inc. diskutieren

Ocular Therapeutix Inc.

WKN: A1180P / Symbol: OCUL / Name: Ocular / Aktie / Ausrüstung & Versorgung / Small Cap /

4,47 €
5,66 %

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) 26,28 %
Kursziel 10,95
Veränderung
Endet am 08.08.24

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) 31,10 %
Kursziel 16,88
Veränderung
Endet am 14.09.24

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $18.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) 67,08 %
Kursziel 11,40
Veränderung
Endet am 04.10.24

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,90 %
Kursziel 13,91
Veränderung
Endet am 09.02.25

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,77 %
Kursziel 11,20
Veränderung
Endet am 14.02.25

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Einschätzung Buy
Rendite (%) -52,44 %
Kursziel 13,83
Veränderung
Endet am 26.02.25

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at Piper Sandler from $10.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for OCUL provided by MarketBeat

Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat

Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat